Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

This study has been completed.
Information provided by (Responsible Party):
IMPAX Laboratories, Inc. Identifier:
First received: June 18, 2007
Last updated: September 8, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 27, 2013